Press Releases

Date Title and Summary
Toggle Summary Accuray Showcases CyberKnife Robotic Radiosurgery System at American Urological Association Meeting
Company's Symposium Highlights Five-Year CyberKnife Prostate SBRT Outcomes, Demonstrates Treatment's Long-Term Efficacy SUNNYVALE, Calif. and WASHINGTON, May 16, 2011 /PRNewswire via COMTEX/ -- The American Urological Association (AUA) Meeting, May 16, 2011 -- Accuray Incorporated (Nasdaq: ARAY), a
Toggle Summary 85 Percent of CyberKnife® Sites Within Europe Performing Prostate Stereotactic Body Radiation Therapy (SBRT)
This Recognition of Clinical Benefits Across Europe is Supported by Five-Year Outcomes for Low-Risk Prostate Cancer Patients Treated in Five Sessions SUNNYVALE, Calif., May 11, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery,
Toggle Summary SEC Declares Accuray Form S-4 Registration Statement Effective in Proposed Acquisition of TomoTherapy
SUNNYVALE, Calif., May 9, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the U.S. Securities and Exchange Commission has declared effective the company's Form S-4 Registration Statement relating to the
Toggle Summary Accuray Announces Results for Third Quarter of Fiscal 2011
SUNNYVALE, Calif., May 5, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the third quarter of fiscal year 2011, ended March 31, 2011 . For the third quarter of fiscal 2011, Accuray reported
Toggle Summary Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
SUNNYVALE, Calif., April 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in
Toggle Summary Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2011
SUNNYVALE, Calif., April 14, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that it will report results for its third quarter of fiscal 2011, ended March 31, 2011 on Thursday, May 5, 2011 after the market closes.
Toggle Summary Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference
SUNNYVALE, Calif., March 28, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the 10th Annual Needham Healthcare Conference in New York City on Tuesday, April 5, 2011 at
Toggle Summary Accuray to Acquire TomoTherapy for Approximately $277 Million in Cash and Stock
Combination of Two Best-in-Class Technologies Creates the Premier Radiation Oncology Company Acquisition Expected to be Accretive to Accuray's FY2013 Earnings SUNNYVALE, Calif. and MADISON, Wis., March 7, 2011 /PRNewswire via COMTEX/ -- Accuray (Nasdaq: ARAY), a global leader in the field of
Toggle Summary Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award
Silicon Valley/San Jose Business Journal Names Accuray's Darren Milliken Best General Counsel for a Small Public Company SUNNYVALE, Calif., Feb. 25, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Senior
Toggle Summary CyberKnife(R) Robotic Radiosurgery Summit Provides Forum for Clinicians to Share Knowledge and Experience
SUNNYVALE, Calif., Feb. 14, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today the completion of the annual CyberKnife Scientific Meeting held February 10-12, 2011 , in San Francisco, Calif.

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.